277 related articles for article (PubMed ID: 33933885)
1. Modelling studies reveal the importance of the C-terminal inter motif loop of NSP1 as a promising target site for drug discovery and screening of potential phytochemicals to combat SARS-CoV-2.
Prabhu D; Rajamanikandan S; Sureshan M; Jeyakanthan J; Saraboji K
J Mol Graph Model; 2021 Jul; 106():107920. PubMed ID: 33933885
[TBL] [Abstract][Full Text] [Related]
2. Drug targeting Nsp1-ribosomal complex shows antiviral activity against SARS-CoV-2.
Afsar M; Narayan R; Akhtar MN; Das D; Rahil H; Nagaraj SK; Eswarappa SM; Tripathi S; Hussain T
Elife; 2022 Mar; 11():. PubMed ID: 35323109
[TBL] [Abstract][Full Text] [Related]
3. Virtual Screening of
Miandad K; Ullah A; Bashir K; Khan S; Abideen SA; Shaker B; Alharbi M; Alshammari A; Ali M; Haleem A; Ahmad S
Molecules; 2022 Nov; 27(22):. PubMed ID: 36432204
[TBL] [Abstract][Full Text] [Related]
4. Emerging of a SARS-CoV-2 viral strain with a deletion in nsp1.
Benedetti F; Snyder GA; Giovanetti M; Angeletti S; Gallo RC; Ciccozzi M; Zella D
J Transl Med; 2020 Aug; 18(1):329. PubMed ID: 32867854
[TBL] [Abstract][Full Text] [Related]
5. Structure of Nonstructural Protein 1 from SARS-CoV-2.
Clark LK; Green TJ; Petit CM
J Virol; 2021 Jan; 95(4):. PubMed ID: 33234675
[TBL] [Abstract][Full Text] [Related]
6. The N-terminal domain of SARS-CoV-2 nsp1 plays key roles in suppression of cellular gene expression and preservation of viral gene expression.
Mendez AS; Ly M; González-Sánchez AM; Hartenian E; Ingolia NT; Cate JH; Glaunsinger BA
Cell Rep; 2021 Oct; 37(3):109841. PubMed ID: 34624207
[TBL] [Abstract][Full Text] [Related]
7. Dynamic competition between SARS-CoV-2 NSP1 and mRNA on the human ribosome inhibits translation initiation.
Lapointe CP; Grosely R; Johnson AG; Wang J; Fernández IS; Puglisi JD
Proc Natl Acad Sci U S A; 2021 Feb; 118(6):. PubMed ID: 33479166
[TBL] [Abstract][Full Text] [Related]
8. Structure of the SARS-CoV-2 Nsp1/5'-Untranslated Region Complex and Implications for Potential Therapeutic Targets, a Vaccine, and Virulence.
Vankadari N; Jeyasankar NN; Lopes WJ
J Phys Chem Lett; 2020 Nov; 11(22):9659-9668. PubMed ID: 33135884
[TBL] [Abstract][Full Text] [Related]
9. Two Ligand-Binding Sites on SARS-CoV-2 Non-Structural Protein 1 Revealed by Fragment-Based X-ray Screening.
Ma S; Damfo S; Lou J; Pinotsis N; Bowler MW; Haider S; Kozielski F
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293303
[TBL] [Abstract][Full Text] [Related]
10. Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2.
Thoms M; Buschauer R; Ameismeier M; Koepke L; Denk T; Hirschenberger M; Kratzat H; Hayn M; Mackens-Kiani T; Cheng J; Straub JH; Stürzel CM; Fröhlich T; Berninghausen O; Becker T; Kirchhoff F; Sparrer KMJ; Beckmann R
Science; 2020 Sep; 369(6508):1249-1255. PubMed ID: 32680882
[TBL] [Abstract][Full Text] [Related]
11. A computational approach for rational discovery of inhibitors for non-structural protein 1 of SARS-CoV-2.
Singh R; Bhardwaj VK; Das P; Purohit R
Comput Biol Med; 2021 Aug; 135():104555. PubMed ID: 34144270
[TBL] [Abstract][Full Text] [Related]
12. Identification of the binding interactions of some novel antiviral compounds against Nsp1 protein from SARS-CoV-2 (COVID-19) through high throughput screening.
Chowdhury N; Bagchi A
J Biomol Struct Dyn; 2022 Sep; 40(14):6634-6641. PubMed ID: 33612076
[TBL] [Abstract][Full Text] [Related]
13. Multi-target potential of Indian phytochemicals against SARS-CoV-2: A docking, molecular dynamics and MM-GBSA approach extended to Omicron B.1.1.529.
Roshni J; Vaishali R; Ganesh KS; Dharani N; Alzahrani KJ; Banjer HJ; Alghamdi AH; Theyab A; Ahmed SS; Patil S
J Infect Public Health; 2022 Jun; 15(6):662-669. PubMed ID: 35617830
[TBL] [Abstract][Full Text] [Related]
14. Targeting stem-loop 1 of the SARS-CoV-2 5' UTR to suppress viral translation and Nsp1 evasion.
Vora SM; Fontana P; Mao T; Leger V; Zhang Y; Fu TM; Lieberman J; Gehrke L; Shi M; Wang L; Iwasaki A; Wu H
Proc Natl Acad Sci U S A; 2022 Mar; 119(9):. PubMed ID: 35149555
[TBL] [Abstract][Full Text] [Related]
15. An Evolutionarily Conserved Strategy for Ribosome Binding and Host Translation Inhibition by β-coronavirus Non-structural Protein 1.
Maurina SF; O'Sullivan JP; Sharma G; Pineda Rodriguez DC; MacFadden A; Cendali F; Henen MA; Vögeli B; Kieft JS; Glasgow A; Steckelberg AL
J Mol Biol; 2023 Oct; 435(20):168259. PubMed ID: 37660941
[TBL] [Abstract][Full Text] [Related]
16. Structure-Based Virtual Screening Identifies Multiple Stable Binding Sites at the RecA Domains of SARS-CoV-2 Helicase Enzyme.
Ahmad S; Waheed Y; Ismail S; Bhatti S; Abbasi SW; Muhammad K
Molecules; 2021 Mar; 26(5):. PubMed ID: 33800013
[TBL] [Abstract][Full Text] [Related]
17. Virtual Screening of Phytochemicals by Targeting HR1 Domain of SARS-CoV-2 S Protein: Molecular Docking, Molecular Dynamics Simulations, and DFT Studies.
Majeed A; Hussain W; Yasmin F; Akhtar A; Rasool N
Biomed Res Int; 2021; 2021():6661191. PubMed ID: 34095308
[TBL] [Abstract][Full Text] [Related]
18. Clinically observed deletions in SARS-CoV-2 Nsp1 affect its stability and ability to inhibit translation.
Kumar P; Schexnaydre E; Rafie K; Kurata T; Terenin I; Hauryliuk V; Carlson LA
FEBS Lett; 2022 May; 596(9):1203-1213. PubMed ID: 35434785
[TBL] [Abstract][Full Text] [Related]
19. Virtual screening of phytochemicals by targeting multiple proteins of severe acute respiratory syndrome coronavirus 2: Molecular docking and molecular dynamics simulation studies.
Azeem M; Mustafa G; Mahrosh HS
Int J Immunopathol Pharmacol; 2022; 36():3946320221142793. PubMed ID: 36442514
[TBL] [Abstract][Full Text] [Related]
20. Unravelling lead antiviral phytochemicals for the inhibition of SARS-CoV-2 M
Gurung AB; Ali MA; Lee J; Farah MA; Al-Anazi KM
Life Sci; 2020 Aug; 255():117831. PubMed ID: 32450166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
